Increasing revenues of Wholesale Pharmaceutical Suppliers cannot be directly related to growth of the pharmaceutical industry of India, because the wholesalers not only supply finished goods in India but are also involved in exporting drugs to various countries across the globe. Determining the exact split of revenue which will be sum of import revenue and export revenue of every wholesaler is a cumbersome task. both markets i.e. domestic and export market are showing robust growth since last half decade or so and by the looks of it there seems to be a lot of robust growth in coming years too. India is not only one of the biggest drug manufacturers in the world but also one of the biggest consumers thanks to the humungous population which resides in the country. In Asia, India is the only country which has been emerging as a big player in the drug industry. A lot of international names have been planning to invest and set up their unit in India. The fact that India has a vast coastline across east, west and southern region sets up a huge opportunity to ship drugs across different continents of the world. Young educated population, increasing medical tourism and availability of cheap skilled labour are the prime reasons that has been exciting these manufacturers to have their shop in India.
Healthcare industry in india is fast becoming more professional and organised. This has opened up new prospects at various levels. One such forecasted opportunity is Clinical Trial Supply. it is a getting larger and more complex by the day. This is so because it is not confined and is spreading to all corners of the world. Also the timeframes within which it was being executed is decreasing. A lot of these trials are outsourced, hence the term 'supply'. Eventually both the client and the vendor have one goal i.e. to achieve patent and rights and effective production and supply at the right time. There are a lot of issues these trials run into. Therefore we are seeing a lot of changes in practices to improve efficiency of clinical trial supply and its chain management. The highlight amongst these practices have been reverse engineering or working backwards, maintaining stock levels and trial supplies, forecasting programs, data maintenance in electronic format and complete manual approach. All the countries which practice clinical trial supply have adopted these changes. The results have been very optimistic too. As consumers we do not understand these changes but wholesalers and distributors across the world are fiercely involved in being the first ones either to bring an innovative change or adapt quickly to the changes.